Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity

• 收藏
• 分享

专利权人:

Novartis AG;Dana-Farber Cancer Institute Inc.

发明人:

Griffin James Douglas,Manley Paul William

申请号：

HU0401642

公开号：

HU230798B1

申请日:

2002.10.29

申请国别(地区):

HU

年份:

2018

代理人:

摘要：

The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving deregulated FLT3 receptor tyrosine kinase activity, especially for the curative and/or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving deregulated FLT3 receptor tyrosine kinase activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/